SCHEMBL12817644

SCHEMBL12817644

Cc1nc2ccc(S(=O)(=O)N3CCSc4ccc(-c5ccc(C#N)s5)cc43)cc2o1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 3/20 0.37
▸ CPT2 P23786 2/20 0.34
▸ CPT1A P50416 2/20 0.34
▸ CPT1B Q92523 2/20 0.34
▸ GCK P35557 1/20 0.34
▸ CNR1 P21554 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ RORC P51449 4/20 0.32
▸ NR1I2 O75469 1/20 0.32
▸ NR1H2 P55055 1/20 0.32
▸ NR1H3 Q13133 1/20 0.32
▸ GPR119 Q8TDV5 1/20 0.31
▸ LMNA P02545 2/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ PKM P14618 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12819156 0.93 PGR (0.39) PGRCPT2CPT1ACPT1BGCK
SCHEMBL12818327 0.87 CYP11B1 (0.38) CPT2CPT1ACPT1BCNR1CNR2
SCHEMBL12818990 0.85 CYP2C9 (0.38) PGRCPT1ACPT1BGCKALDH1A1
SCHEMBL12818019 0.85 PKM (0.42) CPT2CPT1ACPT1BLMNAALDH1A1
SCHEMBL12818273 0.84 PGR (0.36) PGRGCK
SCHEMBL12818376 0.84 PGR (0.38) PGRGCKLMNAALDH1A1PKM
SCHEMBL12818379 0.84 PGR (0.38) PGRCPT2CPT1ACPT1BGCK
SCHEMBL12817683 0.83 CPT2 (0.34) PGRCPT2CPT1ACPT1BCNR1
SCHEMBL12817920 0.81 CYP11B1 (0.40) PGRCPT2CPT1ACPT1BCNR1
SCHEMBL12817890 0.80 HSPD1 (0.40) PGRCPT2CPT1ACPT1BGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback